March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Get the basics about STDs: who gets them, why they are important, and how to protect yourself. Also learn about ten of the most common STDs.
Learn about the importance of dental care, how using tobacco and/or street drugs affects your mouth, and oral conditions common in HIV+ people.